ArticleFrontiers in endocrinology2026
Interpretable hybrid deep learning features of pectoralis on low-dose chest CT for detecting type 2 diabetes.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To develop an explainable hybrid deep learning features framework using low-dose chest CT (LDCT)-derived pectoralis features for opportunistic type 2 diabetes mellitus (T2DM) opportunistic screening, evaluating its incremental value over conventional biomarkers. Methods: This multi-center study analyzed LDCT images from 1,209 individuals. Following automated MedSAM segmentation, conventional metrics (e.g., Mean_HU, SMI) and deep learning (DL) features (ResNet152) were extracted. To prevent data leakage, PCA, LASSO selection, and ExtraTrees model optimization were strictly confined to the training set. A hybrid (COM) model integrating both feature types was compared against a baseline Muscle model. SHapley Additive exPlanations (SHAP) provided clinical interpretability. Results: The COM model achieved an area under the curve (AUC) of 0.830 (training), 0.759 (internal validation), and 0.746 (external validation). While performing comparably to the DL model without significant difference across validation cohorts (DeLong p > 0.05), it significantly outperformed the baseline Muscle model (external AUC: 0.515; DeLong test, p < 0.001). SHAP analysis confirmed that lower Mean_HU correlated with higher T2DM risk, while DL signatures provided robust, independent diagnostic value. Conclusion: This explainable hybrid model and DL model capture sub-visual pectoralis alterations, offering significant incremental diagnostic value over simple clinical and imaging metrics. They serves as an efficient, non-invasive tool for opportunistic T2DM screening during routine LDCT.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.